Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 03:00PM ET
18.68
Dollar change
+0.40
Percentage change
2.19
%
IndexRUT P/E- EPS (ttm)-3.14 Insider Own3.49% Shs Outstand38.21M Perf Week-3.41%
Market Cap713.85M Forward P/E- EPS next Y-0.91 Insider Trans0.00% Shs Float36.88M Perf Month-3.76%
Income-119.03M PEG- EPS next Q-0.27 Inst Own91.41% Short Float4.51% Perf Quarter7.36%
Sales784.25M P/S0.91 EPS this Y31.88% Inst Trans-3.63% Short Ratio6.42 Perf Half Y48.96%
Book/sh13.76 P/B1.36 EPS next Y67.67% ROA-13.42% Short Interest1.66M Perf Year58.84%
Cash/sh0.85 P/C21.93 EPS next 5Y9.40% ROE-20.86% 52W Range11.17 - 20.73 Perf YTD38.58%
Dividend Est.- P/FCF- EPS past 5Y- ROI-17.73% 52W High-9.89% Beta1.09
Dividend TTM- Quick Ratio1.11 Sales past 5Y13.08% Gross Margin65.83% 52W Low67.23% ATR (14)0.67
Dividend Ex-Date- Current Ratio2.39 EPS Y/Y TTM19.53% Oper. Margin-10.91% RSI (14)53.54 Volatility3.09% 4.06%
Employees1634 Debt/Eq0.30 Sales Y/Y TTM17.32% Profit Margin-15.18% Recom1.80 Target Price24.40
Option/ShortYes / Yes LT Debt/Eq0.28 EPS Q/Q8.15% Payout- Rel Volume0.26 Prev Close18.28
Sales Surprise0.04% EPS Surprise-105.80% Sales Q/Q6.85% EarningsNov 07 BMO Avg Volume259.33K Price18.68
SMA20-0.54% SMA507.94% SMA20021.69% Trades Volume57,164 Change2.19%
Date Action Analyst Rating Change Price Target Change
Nov-08-24Upgrade Stifel Hold → Buy $18 → $24
May-08-24Upgrade ROTH MKM Neutral → Buy $15 → $20
Oct-20-23Initiated ROTH MKM Neutral $12
Sep-12-23Downgrade Stifel Buy → Hold
Sep-12-23Downgrade BTIG Research Buy → Neutral
Jul-19-23Resumed BTIG Research Buy $27
Mar-04-22Upgrade Stifel Hold → Buy $41 → $45
Oct-20-20Initiated Stifel Hold $39
Oct-29-19Downgrade Cantor Fitzgerald Overweight → Neutral $71 → $48
Jun-01-18Initiated Cantor Fitzgerald Overweight
Nov-12-24 07:05AM
Nov-08-24 07:32AM
02:14AM
Nov-07-24 08:25AM
07:23AM
07:05AM Loading…
07:05AM
07:05AM
Nov-06-24 07:30AM
Oct-21-24 07:00AM
Oct-10-24 07:00AM
Oct-09-24 12:34PM
Sep-27-24 05:45AM
Sep-23-24 07:00AM
Sep-13-24 05:45AM
Aug-30-24 10:22AM
05:52PM Loading…
Aug-15-24 05:52PM
Aug-07-24 06:09AM
Aug-06-24 08:15AM
07:17AM
07:03AM
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Jul-10-24 12:13PM
06:32AM
Jul-09-24 07:00AM
07:00AM
Jun-24-24 07:00AM
03:11AM
Jun-18-24 07:00AM
Jun-11-24 07:00AM
07:00AM Loading…
May-23-24 07:00AM
May-16-24 07:15AM
May-13-24 11:18AM
May-09-24 07:00AM
May-08-24 01:03PM
07:43AM
03:16AM
May-07-24 10:38PM
01:53PM
09:34AM
08:21AM
08:00AM
Apr-26-24 06:37AM
Apr-23-24 07:00AM
Apr-16-24 07:00AM
Mar-18-24 07:00AM
Mar-12-24 11:01AM
Mar-07-24 01:40PM
09:53AM
Mar-06-24 08:21AM
Mar-05-24 10:52PM
04:42PM
04:03PM
Feb-29-24 07:00AM
Feb-21-24 07:00AM
Jan-18-24 07:00AM
Jan-16-24 07:00AM
Jan-09-24 08:00AM
Jan-08-24 07:00AM
Dec-27-23 08:45AM
Dec-21-23 07:00AM
Dec-12-23 07:00AM
Dec-11-23 09:55AM
Dec-01-23 06:16PM
Nov-29-23 12:21PM
07:00AM
Nov-28-23 11:30AM
07:00AM
Nov-27-23 10:48AM
Nov-24-23 12:28PM
Nov-23-23 09:55AM
Nov-21-23 06:30PM
Nov-13-23 09:00AM
Nov-09-23 01:43PM
Nov-08-23 05:36PM
04:07PM
09:00AM
Nov-07-23 03:59PM
Nov-06-23 07:00AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
Oct-31-23 01:48PM
Oct-29-23 09:00PM
Oct-23-23 09:00PM
03:54PM
Oct-18-23 09:00PM
07:00AM
Oct-17-23 08:33AM
Oct-13-23 09:00PM
08:40PM
08:23AM
Oct-12-23 09:10AM
07:00AM
Oct-09-23 05:25PM
01:48PM
Oct-08-23 09:00PM
Oct-06-23 09:13AM
Oct-02-23 09:00PM
Sep-27-23 09:00PM
Sep-21-23 09:22AM
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kenny Kevin J.President of Global SpineJan 08 '24Option Exercise0.005,9590147,321Jan 10 04:55 PM